These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26645208)

  • 1. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
    Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
    Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FKBP5 polymorphism is associated with major depression but not with bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Narozna B; Rajewska-Rager A; Wilkosc M; Zaremba D; Maciukiewicz M; Twarowska-Hauser J
    J Affect Disord; 2014 Aug; 164():33-7. PubMed ID: 24856550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in FKBP5 affecting response to antidepressant drug treatment.
    Kirchheiner J; Lorch R; Lebedeva E; Seeringer A; Roots I; Sasse J; Brockmöller J
    Pharmacogenomics; 2008 Jul; 9(7):841-6. PubMed ID: 18597649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.
    Menke A; Klengel T; Rubel J; Brückl T; Pfister H; Lucae S; Uhr M; Holsboer F; Binder EB
    Genes Brain Behav; 2013 Apr; 12(3):289-96. PubMed ID: 23406438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls.
    Höhne N; Poidinger M; Merz F; Pfister H; Brückl T; Zimmermann P; Uhr M; Holsboer F; Ising M
    Int J Neuropsychopharmacol; 2014 Dec; 18(4):. PubMed ID: 25522420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.
    Lekman M; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ; Paddock S
    Biol Psychiatry; 2008 Jun; 63(12):1103-10. PubMed ID: 18191112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression.
    Tozzi L; Carballedo A; Wetterling F; McCarthy H; O'Keane V; Gill M; Morris D; Fahey C; Meaney J; Frodl T
    Neuropsychopharmacology; 2016 Jan; 41(2):487-97. PubMed ID: 26076833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.
    Adli M; Wiethoff K; Baghai TC; Fisher R; Seemüller F; Laakmann G; Brieger P; Cordes J; Malevani J; Laux G; Hauth I; Möller HJ; Kronmüller KT; Smolka MN; Schlattmann P; Berger M; Ricken R; Stamm TJ; Heinz A; Bauer M
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):721-730. PubMed ID: 28645191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression.
    Tozzi L; Farrell C; Booij L; Doolin K; Nemoda Z; Szyf M; Pomares FB; Chiarella J; O'Keane V; Frodl T
    Neuropsychopharmacology; 2018 Apr; 43(5):1138-1145. PubMed ID: 29182159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expression.
    Fujii T; Hori H; Ota M; Hattori K; Teraishi T; Sasayama D; Yamamoto N; Higuchi T; Kunugi H
    Psychoneuroendocrinology; 2014 Apr; 42():89-97. PubMed ID: 24636505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study.
    Kang JI; Chung HC; Jeung HC; Kim SJ; An SK; Namkoong K
    Psychoneuroendocrinology; 2012 Sep; 37(9):1569-76. PubMed ID: 22459275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder.
    Han KM; Won E; Sim Y; Kang J; Han C; Kim YK; Kim SH; Joe SH; Lee MS; Tae WS; Ham BJ
    Sci Rep; 2017 Feb; 7():42621. PubMed ID: 28198448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.
    Bauer M; Pfennig A; Linden M; Smolka MN; Neu P; Adli M
    J Clin Psychopharmacol; 2009 Aug; 29(4):327-33. PubMed ID: 19593170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.
    Shinozaki G; Jowsey S; Amer H; Biernacka J; Colby C; Walker D; Black J; Rundell J; Stegall M; Mrazek DA
    Depress Anxiety; 2011 Dec; 28(12):1111-8. PubMed ID: 22134958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506-binding protein 51 (FKBP5) gene polymorphism is not associated with glucocorticoid therapy outcome in patients with idiopathic thrombocytopenic purpura.
    Lao W; Fang M; Yang X
    Mol Med Rep; 2012 Oct; 6(4):787-90. PubMed ID: 22825419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
    Wiethoff K; Bauer M; Baghai TC; Möller HJ; Fisher R; Hollinde D; Kiermeir J; Hauth I; Laux G; Cordes J; Brieger P; Kronmüller KT; Zeiler J; Adli M
    J Clin Psychiatry; 2010 Aug; 71(8):1047-54. PubMed ID: 20673545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.